Insider Trading: ResMed Inc (RMD)

RMD on New York Consolidated

50.08USD
21 May 2013
Price Change (% chg)

$0.10 (+0.20%)
Prev Close
$50.07
Open
$49.76
Day's High
$50.23
Day's Low
$49.59
Volume
540,694
Avg. Vol
1,047,154
52-wk High
$51.40
52-wk Low
$29.82

Search Stocks
SANDERCOCK BRETT A Options Exercised: 0
Trade Date: Tuesday, 1 May 2012 Price: 34.75
Title: Chief Financial Officer Shares Held: 52,969
Type Traded: Direct Net Change in Shares This Filing: -20,000
» More Insider Trading

Institutional Holders

% Shares Owned: 54.94%
# of Holders: 371
Total Shares Held: 78,270,053
3 Mo. Net Change: 1,297,864
# New Positions: 32
# Closed Positions: 34
# Increased Positions: 175
# Reduced Positions: 157
# Net Buyers: 18

Officers & Directors

Name Age Since Current Position

Peter Farrell

 70 2014 Non-Executive Chairman of the Board

Robert Douglas

 53 2013 President, Chief Operating Officer

Michael Farrell

 40 2013 Chief Executive Officer, Director

Brett Sandercock

 45 2006 Chief Financial Officer

Don Darkin

 59 2011 President - Sleep-disordered Breathing Strategic Business Unit

Jim Hollingshead

 49 2013 President - Americas

Anne Reiser

 51 2012 President, Europe

David Pendarvis

 53 2011 Chief Administrative Officer, Global General Counsel, Company Secretary

Gary Pace

 2010 Lead Independent Director

Michael Quinn

 65 1992 Independent Director

Christopher Roberts

 58 2003 Independent Director

Richard Sulpizio

 61 2005 Independent Director

Ronald Taylor

 65 2005 Independent Director

John Wareham

 71 2005 Independent Director
Search Stocks